Altria Group Stock Forecast
NYSE: MOHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 7, 4:03 PM ET · Delayed 15 min
MO analyst consensus
Consensus (14 analysts)
hold
Avg. price target
$70.00+0.89%
- Strong buy 0
- Buy 4
- Hold 8
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 14 Wall Street analysts covering Altria Group (2026-10-07), 4 rate the stock a buy or strong buy, 8 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $70.00, with a high estimate of $82.00 and a low estimate of $58.00. The average target implies upside of 0.9% from the current price of $69.38.
The spread between the highest and lowest targets is 41.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for MO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 29% |
| Hold | 8 | 57% |
| Sell | 1 | 7% |
| Strong sell | 1 | 7% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $58.00 | -16.40% |
| Average target | $70.00 | +0.89% |
| High target | $82.00 | +18.19% |